Mizuho Medy Co., Ltd. (4595) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Mizuho Medy Co., Ltd.

Jins Holdings, Inc.

Shofu, Inc.

FRANCE BED HOLDINGS CO., LTD.

Menicon Co., Ltd.

Medikit Co., Ltd.

Japan Lifeline Co., Ltd.

Eiken Chemical Co., Ltd.

CYBERDYNE, Inc.

Hogy Medical Co., Ltd.

Takara Bio, Inc.

Why is Mizuho Medy Co., Ltd. ?

High Management Efficiency with a high ROE of 37.40%

Company has very low debt and has enough cash to service the debt requirements

Healthy long term growth as Net Sales has grown by an annual rate of 14.89% and Operating profit at 45.79%

Positive results in Dec 25

RAW MATERIAL COST(Y) Fallen by -2.49% (YoY)
CASH AND EQV(HY) Highest at JPY 21,682 MM
NET SALES(Q) Highest at JPY 5,034 MM

With ROE of 21.09%, it has a very attractive valuation with a 1.72 Price to Book Value

The stock is trading at a premium compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of 20.08%, its profits have fallen by -10.4%

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to Mizuho Medy Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Mizuho Medy Co., Ltd. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Mizuho Medy Co., Ltd.

20.08%

0.15

18.04%

Japan Nikkei 225

36.73%

1.30

28.24%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

14.89%

EBIT Growth (5y)

45.79%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt is too low

Net Debt to Equity (avg)

-0.65

Sales to Capital Employed (avg)

0.72

Tax Ratio

26.30%

Dividend Payout Ratio

50.49%

Pledged Shares

Institutional Holding

ROCE (avg)

112.71%

ROE (avg)

37.40%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.72

EV to EBIT

3.82

EV to EBITDA

3.64

EV to Capital Employed

3.06

EV to Sales

1.61

PEG Ratio

Dividend Yield

ROCE (Latest)

80.22%

ROE (Latest)

21.09%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

10What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -2.49% (YoY

CASH AND EQV(HY)

Highest at JPY 21,682 MM

NET SALES(Q)

Highest at JPY 5,034 MM

OPERATING PROFIT(Q)

Highest at JPY 2,520 MM

OPERATING PROFIT MARGIN(Q)

Highest at 50.06 %

PRE-TAX PROFIT(Q)

Highest at JPY 2,553 MM

NET PROFIT(Q)

Highest at JPY 1,837 MM

EPS(Q)

Highest at JPY 96.44

-5What is not working for the Company

ROCE(HY)

Lowest at 19.01%

DIVIDEND PAYOUT RATIO(Y)

Lowest at 51.85%

DEBT-EQUITY RATIO (HY)

Highest at 0 %

DIVIDEND PER SHARE(HY)

Lowest at JPY 2.09

Here's what is working for Mizuho Medy Co., Ltd.

Net Sales

At JPY 5,034 MM has Grown at 46.34%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very positive

Net Sales (JPY MM)

Net Sales

Highest at JPY 5,034 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (JPY MM)

Operating Profit

Highest at JPY 2,520 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (JPY MM)

Operating Profit Margin

Highest at 50.06 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit

Highest at JPY 2,553 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (JPY MM)

Net Profit

Highest at JPY 1,837 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (JPY MM)

EPS

Highest at JPY 96.44

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (JPY)

Cash and Eqv

Highest at JPY 21,682 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost

Fallen by -2.49% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation

Highest at JPY 68 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (JPY MM)

Here's what is not working for Mizuho Medy Co., Ltd.

Debt-Equity Ratio

Highest at 0 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Dividend per share

Lowest at JPY 2.09

in the last five years

MOJO Watch

Company is distributing lower dividend than previous years

DPS (JPY)

Dividend Payout Ratio

Lowest at 51.85%

in the last five years

MOJO Watch

Company is distributing lower proportion of profits generated as dividend

DPR (%)